K092275

Substantially Equivalent

RANDOX ECSTASY (MDMA) ASSAY

Applicant: Randox Laboratories, Ltd.
Product code: DKZ
Advisory panel: Clinical Toxicology
Date received: 2009-07-28
Decision date: 2011-03-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Crumlin, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.